Engkang, Humaydi A.
HRN: 22-34-70 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/22/2022
BENZYL PENICILLIN 5MU (VIAL)
12/22/2022
12/25/2022
INTRAMUSCULAR
2.4 MU
4x Weekly
Immunocompromised, Syphilis, Fistula In Ano
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes